GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Neuroscience and Physiology / Inst för neurovetenskap och fysiologi >
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi >

Serotonin in Fear and Anxiety


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/65128

Files in This Item:

File Description SizeFormat
gupea_2077_65128_2.pdfAbstract214KbAdobe PDF
View/Open
gupea_2077_65128_6.pdfThesis frame728KbAdobe PDF
View/Open
Title: Serotonin in Fear and Anxiety
Authors: Hagsäter, Melker
E-mail: melker.hagsater@neuro.gu.se
Issue Date: 16-Oct-2020
University: University of Gothenburg. Sahlgrenska Academy
Institution: Institute of Neuroscience and Physiology. Department of Pharmacology
Parts of work: I. Hagsäter SM, Pettersson R, Holmäng A and Eriksson E, “Serotonin depletion reduces both acquisition and expression of context-conditioned fear”, Submitted

II. Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J and Eriksson E, “A complex impact of the 5-HT2A receptor on conditioned fear revealed by systemic administration of different 5-HT2A ligands including pimavanserin and psilocybin”, Submitted

III. Pettersson R, Hagsäter SM, Carlsson B, Karlsson L and Eriksson E, “Chronic but not acute administration of escitalopram reduces context-conditioned fear”, Submitted

IV. Hagsäter SM, Thorén J, Pettersson R and Eriksson E, “Selective serotonin reuptake inhibition increases noise burst-induced unconditioned and context conditioned freezing”, Acta Neuropsychiatrica, 2019, 31, 46-51,
VIEW ARTICLE


V. Hagsäter SM, Lisinski A and Eriksson E, “5-HT6 receptor antagonism reduces defecation in rat: A potential treatment strategy for irritable bowel syndrome with diarrhea”, European Journal of Pharmacology, 2019, 864, 172718,
VIEW ARTICLE

Date of Defence: 2020-11-06
Disputation: Fredagen den 6 november 2020, kl. 13.00, Hörsal Carl Kylberg, Medicinaregatan 7B, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: serotonin
anxiety
fear
SSRI
IBS
Abstract: That the neurotransmitter serotonin (5-HT) has a central role in fear and anxiety is supported by numerous experimental and clinical studies. Arguably the most illustrative example is the effect of serotonergic-acting drugs, and in particular the selective serotonin reuptake inhibitors (SSRIs), in the treatment of anxiety disorders. Interestingly, long-term administration is required to induce a dampening effect on anxiety, while on the contrary acute administration can aggravate the sympto... more
ISBN: 978-91-8009-001-8 (PDF)
978-91-8009-000-1 (PRINT)
URI: http://hdl.handle.net/2077/65128
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi

 

 

© Göteborgs universitet 2011